We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

223 hedge funds and large institutions have $1.35B invested in Myriad Genetics in 2016 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 85 increasing their positions, 71 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

117.94% more ownership

Funds ownership: 0% → 117.94% (+118%)

20% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 71

11% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 37

0% more funds holding

Funds holding: 223 → 223 (0)

20% less capital invested

Capital invested by funds: $1.7B → $1.35B (-$348M)

74% less call options, than puts

Call options by funds: $5.7M | Put options by funds: $22.1M

Holders
223
Holders Change
–
Holders Change %
0%
% of All Funds
5.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
41
Increased
85
Reduced
71
Closed
37
Calls
$5.7M
Puts
$22.1M
Net Calls
-$16.4M
Net Calls Change
-$13.9M

Top Buyers

1
CCM
Camber Capital Management
Massachusetts
+$73.5M
2
CCM
Consonance Capital Management
New York
+$26.8M
3
Two Sigma Investments
Two Sigma Investments
New York
+$12M
4
FCM
Frontier Capital Management
Massachusetts
+$11M
5
First Trust Advisors
First Trust Advisors
Illinois
+$10.5M

Top Sellers

1
SCM
Scopia Capital Management
New York
-$75.3M
2
Capital Research Global Investors
Capital Research Global Investors
California
-$57.5M
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$24.2M
4
Citadel Advisors
Citadel Advisors
Florida
-$17.1M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$15.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$16.4M -$597K -32,978 -3%
Goldman Sachs
27
Goldman Sachs
New York
$14.5M -$10.3M -569,412 -39%
PA
28
Pinnacle Associates
New York
$14.5M -$935K -51,703 -6%
Norges Bank
29
Norges Bank
Norway
$14.3M +$1.88M +103,927 +14%
Canada Pension Plan Investment Board
30
Canada Pension Plan Investment Board
Ontario, Canada
$14.1M +$1.09M +60,000 +8%
Charles Schwab
31
Charles Schwab
California
$11.2M +$1.86M +102,593 +18%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$10.7M +$333K +18,428 +3%
SAM
33
Senzar Asset Management
New York
$8.25M +$8.96M +495,100 New
Carson Wealth (CWM LLC)
34
Carson Wealth (CWM LLC)
Nebraska
$8.25M +$896K +49,510 +11%
STB
35
S&T Bank
Pennsylvania
$8.16M -$2.81M -155,427 -24%
Mitsubishi UFJ Trust & Banking
36
Mitsubishi UFJ Trust & Banking
Japan
$8M -$89.9K -4,970 -1%
Invesco
37
Invesco
Georgia
$7.67M +$956K +52,816 +13%
Citadel Advisors
38
Citadel Advisors
Florida
$7.14M -$17.1M -943,539 -69%
State Farm Mutual Automobile Insurance
39
State Farm Mutual Automobile Insurance
Illinois
$6.75M +$4.1M +226,353 +127%
CIM
40
Contrarius Investment Management
Jersey
$6.71M +$2.44M +134,664 +50%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$6.63M +$5.72M +315,882 +385%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$6.62M +$333K +18,380 +5%
Citigroup
43
Citigroup
New York
$6.43M +$6.57M +363,402 +1,641%
AQR Capital Management
44
AQR Capital Management
Connecticut
$6.01M +$697K +38,526 +12%
Wells Fargo
45
Wells Fargo
California
$5.88M +$1.74M +96,292 +38%
SI
46
Stephens Inc
Arkansas
$5.18M +$4.35M +240,340 +343%
SIM
47
Spark Investment Management
New York
$4.93M +$747K +41,300 +16%
CIC
48
Chilton Investment Company
Connecticut
$4.85M +$3.36M +185,616 +177%
CS
49
Credit Suisse
Switzerland
$4.84M -$341K -18,868 -6%
GAM
50
Gotham Asset Management
New York
$4.82M -$2.4M -132,686 -31%
1
2
3 4 5

MYGN Hedge Fund Activity: Q4 2016 in Review

223 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q4 2016, worth a combined $1.35B — down 20% from $1.7B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MYGN positions and 37 closed out — a net gain of 4 holders — while 85 added to existing stakes and 71 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $73.5M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $75.3M sold.

  • 223 institutional investors held Myriad Genetics (MYGN) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $1.35B of Myriad Genetics stock for Q4 2016, down 20% quarter-over-quarter.
  • 41 funds opened new Myriad Genetics positions in Q4 2016 and 37 closed out, a net change of +4 holders.
  • The largest Myriad Genetics buyer in Q4 2016 was Camber Capital Management, an estimated $73.5M added.
  • The largest Myriad Genetics seller in Q4 2016 was Scopia Capital Management, an estimated $75.3M sold.

Based on aggregated 13F filings for Q4 2016.